U.S. Health Care Spending on Respiratory Diseases, 1996-2016.
Kevin I DuanMaxwell BirgerDavid H AuLaura J SpeceLaura C FeemsterJoseph L DielemanPublished in: American journal of respiratory and critical care medicine (2022)
US spending on respiratory conditions is high, particularly for chronic conditions like asthma and COPD. Our findings suggest that service price and intensity, particularly for pharmaceuticals, should be a key focus of attention for policy makers seeking to reduce health care spending growth.